Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$113.24 - $131.95 $45,296 - $52,779
400 New
400 $53.1 Million
Q2 2019

Jan 17, 2024

SELL
$69.84 - $81.59 $4.95 Million - $5.79 Million
-70,933 Closed
0 $0
Q1 2019

Jan 17, 2024

SELL
$69.58 - $79.36 $2.78 Million - $3.17 Million
-40,000 Reduced 36.06%
70,933 $5.9 Billion
Q4 2018

Jan 17, 2024

SELL
$65.24 - $75.71 $104,449 - $121,211
-1,601 Reduced 1.42%
110,933 $8.48 Billion
Q3 2018

Jan 17, 2024

SELL
$57.69 - $67.84 $81,862 - $96,264
-1,419 Reduced 1.25%
112,534 $7.98 Billion
Q2 2018

Jan 17, 2024

SELL
$50.83 - $59.72 $1.19 Million - $1.4 Million
-23,444 Reduced 17.06%
113,953 $6.92 Billion
Q1 2018

Jan 17, 2024

BUY
$50.96 - $59.23 $257,500 - $299,289
5,053 Added 3.82%
137,397 $7.48 Billion
Q4 2017

Jan 17, 2024

BUY
$51.62 - $61.64 $148,304 - $177,091
2,873 Added 2.22%
132,344 $7.45 Billion
Q3 2017

Jan 17, 2024

BUY
$58.67 - $63.13 $101,088 - $108,772
1,723 Added 1.35%
129,471 $8.29 Billion
Q2 2017

Jan 17, 2024

BUY
N/A
4,196 Added 3.4%
127,748 $8.19 Billion
Q1 2017

Jan 17, 2024

SELL
N/A
-6,135 Reduced 4.73%
123,552 $7.85 Billion
Q4 2016

Jan 17, 2024

SELL
N/A
-964 Reduced 0.74%
129,687 $7.63 Billion
Q3 2016

Jan 17, 2024

SELL
N/A
-10,640 Reduced 7.53%
130,651 $8.15 Billion
Q2 2016

Jan 17, 2024

SELL
N/A
-661 Reduced 0.47%
141,291 $8.14 Billion
Q1 2016

Jan 17, 2024

SELL
N/A
-4,783 Reduced 3.26%
141,952 $7.51 Billion
Q4 2015

Jan 17, 2024

BUY
N/A
25,451 Added 20.98%
146,735 $7.75 Billion
Q3 2015

Jan 17, 2024

BUY
N/A
57,550 Added 90.3%
121,284 $5.99 Billion
Q2 2015

Jan 17, 2024

BUY
N/A
63,734
63,734 $3.63 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Dixon Mitchell Investment Counsel Inc. Portfolio

Follow Dixon Mitchell Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Mitchell Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dixon Mitchell Investment Counsel Inc. with notifications on news.